P3 Health Partners Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
P3 Health Partners Inc. (PIII) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $10.28 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-10
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $10.28M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.07M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $2.36M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $7.43M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $10.28M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $2.07M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.36M 10-K · filed 2026-03-26 |
| 2025-09-30 | $7.43M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $4.87M 10-Q · filed 2026-08-10 |
| 2025-03-31 | $6.86M 10-Q · filed 2026-05-14 |
| 2024-12-31 | $10.19M 10-K · filed 2026-03-26 |
| 2024-09-30 | $19.30M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $24.50M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $24.00K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $29.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $51.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $67.00K 10-Q · filed 2024-08-07 |
| 2023-03-31 | $24.00K 10-Q · filed 2024-05-08 |
| 2022-12-31 | $40.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $221.88K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $158.18K 10-Q · filed 2022-10-21 |
| 2021-12-31 | $502.28K 10-Q · filed 2022-11-14 |
| 2021-09-30 | $18.38M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $16.98M 10-Q · filed 2022-10-21 |
| 2020-12-31 | $6.32M 10-Q · filed 2022-11-14 |